GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.
Health News is provided as a service to Pharm-a-Care Pharmacies site users by HealthDay. Pharm-a-Care Pharmacies nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.